K Sugita

1.9k citations
41 papers · 1.4k indexed · h-index 21
Topics
Acute Lymphoblastic Leukemia research (9 papers)Chronic Myeloid Leukemia Treatments (8 papers)Immune Cell Function and Interaction (7 papers)
Partner nations
JapanUnited StatesFrance

In The Last Decade

K Sugita

40 papers receiving 1.4k citations

Peers

K Sugita
Comparison fields: 5 of 91
  • Immunology 737
  • Molecular Biology 329
  • Hematology 270
  • Oncology 230
  • Immunology and Allergy 198
Replace DA Williams with:
DA Williams United States
Shalini Pereira United States
H Mizoguchi Japan
S Fuggle United Kingdom
Kimitoshi Imai Japan
S.J. Fisher United States
Howard Ratech United States
Talat H. Malik United Kingdom
Brett A. Premack United States
Brandy Perkins United States
K Sugita relative to DA Williams United States DA Williams's profile →
Citations per field
00.5×4.5×
DA Williams · 1×
Citations per year

Countries citing papers authored by K Sugita

Since Specialization
Citations

This map shows the geographic impact of K Sugita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Sugita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Sugita more than expected).

Fields of papers citing papers by K Sugita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Sugita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Sugita. The network helps show where K Sugita may publish in the future.

Co-authorship network of co-authors of K Sugita

This figure shows the co-authorship network connecting the top 25 collaborators of K Sugita. A scholar is included among the top collaborators of K Sugita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Sugita. K Sugita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 9
3 36
4 11
5 7
6 1
7 28
8 9
9 22
10 20
11 1
12 58
13 14
14 10
15 46
16 19
17 47
18 47
19 126
20 21

About K Sugita

K Sugita is a scholar working on Hematology, Immunology and Allergy and Immunology, having authored 41 papers that have together received 1.4k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (9 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Immunology (737 citations), Immunology and Allergy (198 citations) and Hematology (270 citations). K Sugita has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Chikao Morimoto, Gordon J. Freeman, Claude Gimmi, JG Gribben, AS Freedman, Lee M. Nadler, S F Schlossman, David M. Rothstein, Yusuke Nojima and Stuart F. Schlossman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026